Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Pediatric Type 1 Diabetes
NCT03111433Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Ain Shams University. Primary endpoint: change in soluble interacellular adhesion molecule level at 3 months. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT03111433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03111433.